WHAT'S KNOWN ON THIS SUBJECT: Prenatal lipid-based nutrient supplementation has been demonstrated to increase birth length. However, the impact of this intervention on infant growth and morbidity is unknown.
WHAT THIS STUDY ADDS:Infants from mothers who were given prenatal lipid-based nutrient supplements showed decelerated linear growth. The gain in length at birth related to prenatal lipidbased nutrient supplementation was not sustained during infancy. abstract BACKGROUND AND OBJECTIVES: Prenatal lipid-based nutrient supplements (LNS) have been shown to improve birth anthropometry. However, little is known about the effects of such supplements on infant health. We hypothesized that prenatal LNS compared with multiple micronutrient supplement for pregnant and lactating women would improve survival, growth, and morbidity during infancy.
METHODS:Infants' weight, length, head, chest, and mid-upper arm circumferences were measured during monthly home visits from birth to 12 months of age in the Micronutriments et Santé de la Mère et de l'Enfant-2 trial. Differences in stunting and wasting episodes between study arms were assessed by Cox regression for recurrent event models. Morbidity signs during the 2 weeks before the visits and death cases were also assessed by multilevel analysis accounting for repeated individual measurements.RESULTS: Infant length-for-age growth (-0.033 z score/month; 95% confidence interval: -0.601 to -0.006; P = .018) for the LNS group was inferior to that of the control group. We did not find evidence of significant difference in mortality or morbidity between groups.
CONCLUSIONS:The previously reported positive effect of prenatal LNS on birth length was not sustained during the postnatal phase. Prenatal LNS does not appear to make a long-lasting difference in child linear growth. Pediatrics 2014;133:e1001-e1008 Size at birth and growth in early infancy are important indicators of early childhood survival and health. Newborns with small birth size, reflecting poor intrauterine nutrition and/or prematurity, have an increased riskofinfant mortality and morbidity, 1 impaired child cognitive development, 2 and adverse health outcomes in adulthood. 3 Poor infant growth is associated with higher mortality and neurocognitive delays. 4,5 Stunted growth during the first 2 years is also associated with shorter adult height, reduced economic productivity, and decreased reproductive performance. 5 In 2011, an estimated 165 million children aged ,5 years worldwide had stunted growth, with the majority residing in Asia and sub-Saharan Africa. 6 Prenatal multiple micronutrient (MMN) 7 and balanced energy and protein 8 supplementation result in a significant reduction in small-for-gestational age births (9% and 31%, respectively). However, the results of such interventions on postnatal growth yielded more dispersed results. In 2 prenatal multiple MMN trials in Burkina Faso and Vietnam, the rate of stunting was reduced during infancy 9 and at 2 years, 10 although no difference was seen at 2.5 years in the ...